 AnPac Bio-Medical Science Co., Ltd. AnPac Bio or the Company NASDAQ: ANPC, a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has gained two new insurance customers in China for its cancer screening and detection tests CDA tests using its cancer differentiation analysis, or CDA, technology. 